Healthcare Innovation March 1, 2019
David Raths

Consortium seeks to expand access to high-quality clinical whole genome sequencing for genetic diseases

Eight U.S and Canadian healthcare organizations, researchers and vendors have launched a consortium that will work to expand access to high-quality clinical whole genome sequencing (cWGS) for the diagnosis of genetic diseases.

The Medical Genome Initiative will focus on the publication of common laboratory and clinical best practices for the application of cWGS. Founding members include Baylor Genetics; Broad Institute of MIT and Harvard; HudsonAlpha Institute for Biotechnology; Illumina Inc.; Mayo Clinic; Rady Children’s Institute for Genomic Medicine; The Hospital for Sick Children (SickKids Toronto); and Stanford Medicine.

Rare genetic diseases affect more than 350 million people globally and are a particularly significant source of morbidity...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Precision Medicine, Technology
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more

Share This Article